Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
@article{Durst2007CannabidiolAN, title={Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.}, author={Ronen Durst and Haim Danenberg and Ruth Gallily and Raphael Mechoulam and Keren Meir and Etty Grad and Ronen Beeri and Thea Pugatsch and Elizabet Tarsish and Chaim Lotan}, journal={American journal of physiology. Heart and circulatory physiology}, year={2007}, volume={293 6}, pages={ H3602-7 } }
Cannabidiol (CBD) is a major, nonpsychoactive Cannabis constituent with anti-inflammatory activity mediated by enhancing adenosine signaling. Inasmuch as adenosine receptors are promising pharmaceutical targets for ischemic heart diseases, we tested the effect of CBD on ischemic rat hearts. For the in vivo studies, the left anterior descending coronary artery was transiently ligated for 30 min, and the rats were treated for 7 days with CBD (5 mg/kg ip) or vehicle. Cardiac function was studied…
96 Citations
Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- Medicine, BiologyPediatric Research
- 2008
Administration of CBD after HI reduced short-term brain damage and was associated with extracerebral benefits; moreover, CBD administration wasassociated with cardiac, hemodynamic, and ventilatory beneficial effects.
The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
- Biology, MedicineJournal of cardiovascular pharmacology and therapeutics
- 2015
Cannabidiol treatment significantly decreased the incidence and the duration of ventricular tachycardia, total length of arrhythmias, and the arrhythmia scores compared to control during the reperfusion period and the antiarrhythmic effect of CBD may be mediated through the activation of adenosine A1 receptor.
Cannabidiol Attenuates Methamphetamine-Induced Cardiac Inflammatory Response and Necrosis through The PKA/CREB Signaling Pathway
- Biology, Medicine
- 2021
Results indicate that chronic MA administration leads to cardiotoxicity, including cardiac inflammatory response, fibrosis, and myocardial necrosis, but these effects can be attenuated by CBD pretreatment.
An ultra-low dose of tetrahydrocannabinol provides cardioprotection.
- Biology, MedicineBiochemical pharmacology
- 2013
Pharmacologic effects of cannabidiol on acute reperfused myocardial infarction in rabbits: evaluated with 3.0T cardiac magnetic resonance imaging and histopathology
- Medicine, Biology
- 2015
Cannabidiol therapy reduced AMI size and facilitated restoration of LV function in rabbits induced with reperfusion injury with an experimental imaging platform, demonstrating that this experimental platform has potential theragnostic utility.
Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
- BiologyOxidative medicine and cellular longevity
- 2020
CBD therapy can greatly limit the production of oxygen/nitrogen reactive species, thereby limiting cellular damage, protecting mitochondria, avoiding caspase activation, and regulating ionic homeostasis and can affect myocardial contraction.
Pharmacologic Effects of Cannabidiol on Acute Reperfused Myocardial Infarction in Rabbits: Evaluated With 3.0T Cardiac Magnetic Resonance Imaging and Histopathology
- Medicine, BiologyJournal of cardiovascular pharmacology
- 2015
CBD therapy reduced AMI size and facilitated restoration of left ventricular function in rabbits with an experimental imaging platform, demonstrating that this experimental platform has potential theragnostic utility.
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity.
- BiologyEnvironmental toxicology and pharmacology
- 2013
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
- Medicine, BiologyInternational journal of molecular sciences
- 2020
Although CBD has been found to exhibit vasodilatory and antioxidant properties in hypertension, it has not affected blood pressure in hypertensive animals, and further clinical research is needed to recommend the use of CBD in the treatment of cardiovascular diseases.
Cannabidiol‐mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage
- BiologyPharmacology research & perspectives
- 2021
The use of cannabinoids was shown to have beneficial effects when used as a treatment for myocardial reperfusion damage, improving considerably the cardiovascular functionality with the use of CBD.
References
SHOWING 1-10 OF 46 REFERENCES
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 2000
Data show that CBD, through its combined immunosuppressive and anti-inflammatory actions, has a potent anti-arthritic effect in CIA.
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.
- Biology, MedicineCardiovascular research
- 2002
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.
- Medicine, BiologyLife sciences
- 2003
Infarct-Sparing Effect of A2A-Adenosine Receptor Activation Is Due Primarily to Its Action on Lymphocytes
- Biology, MedicineCirculation
- 2005
The results indicate that A2AAR activation on bone marrow–derived cells, specifically T or B lymphocytes, is responsible for the infarct-sparing and antiinflammatory effects of ATL146e administered at the time of reperfusion after coronary occlusion.
Cardioprotection With Adenosine A2 Receptor Activation at Reperfusion
- Biology, MedicineJournal of cardiovascular pharmacology
- 2005
While the experimental data suggest that factors such as adenosine A2 receptor activation, anti-neutrophil effect, attenuation of free radical generation, increased nitric oxide (NO) availability, activation of the PI3-kinase/Akt pathway and ERK, prevention of mitochondrial damage, and anti-apoptotic effects may be involved in the protective effect ofAdenosine or its analogues, the exact receptor subtype(s), the detailed signaling mechanisms, and
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
- Medicine, ChemistryEuropean journal of pharmacology
- 2001
Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes
- Biology, MedicineCirculation
- 2006
It is shown that CD4+ but not CD8+ T lymphocytes contribute to myocardial ischemia/reperfusion injury and is strongly suggested that the infarct-sparing effect of A2AR activation is primarily due to inhibition of CD4-cell accumulation and activation in the reperfused heart.
Targeting C-reactive protein for the treatment of cardiovascular disease
- Biology, MedicineNature
- 2006
Therapeutic inhibition of CRP is a promising new approach to cardioprotection in acute myocardial infarction and may also provide neuroprotection in stroke and potential wider applications include other inflammatory, infective and tissue-damaging conditions characterized by increased CRP production.
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
- Biology, ChemistryProceedings of the National Academy of Sciences of the United States of America
- 2006
It is demonstrated that CBD has the ability to enhance adenosine signaling through inhibition of uptake and provide a non-cannabinoid receptor mechanism by which CBD can decrease inflammation.